RREMX
Price
$16.97
Change
-$0.05 (-0.29%)
Updated
Nov 19 closing price
Net Assets
5.29B
VEIEX
Price
$34.03
Change
-$0.05 (-0.15%)
Updated
Nov 19 closing price
Net Assets
141.19B
Interact to see
Advertisement

RREMX vs VEIEX

Header iconRREMX vs VEIEX Comparison
Open Charts RREMX vs VEIEXBanner chart's image
RBC Emerging Markets Equity R6
Price$16.97
Change-$0.05 (-0.29%)
VolumeN/A
Net Assets5.29B
Vanguard Emerging Mkts Stock Idx I
Price$34.03
Change-$0.05 (-0.15%)
VolumeN/A
Net Assets141.19B
RREMX vs VEIEX Comparison Chart in %
View a ticker or compare two or three
VS
RREMX vs. VEIEX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RREMX is a Hold and VEIEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 141B vs. RREMX (5.29B). VEIEX pays higher dividends than RREMX: VEIEX (2.61) vs RREMX (0.71). RREMX was incepted earlier than VEIEX: RREMX (9 years) vs VEIEX (32 years). RREMX (0.89) is less costly to investors than VEIEX (0.29). RREMX is a more actively managed with annual turnover of: 16.00 vs. VEIEX (8.00). VEIEX has a lower initial minimum investment than RREMX: VEIEX (0) vs RREMX (250000). RREMX annual gain was more profitable for investors over the last year : 25.65 vs. VEIEX (20.18). RREMX return over 5 years is better than : 29.91 vs. VEIEX (23.38).
RREMXVEIEXRREMX / VEIEX
Total Expense Ratio0.880.29303%
Annual Report Gross Expense Ratio0.890.29307%
Fund Existence9 years32 years-
Gain YTD29.13522.205131%
Front LoadN/AN/A-
Min. Initial Investment2500000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.29B141B4%
Annual Yield % from dividends0.712.6127%
Returns for 1 year25.6520.18127%
Returns for 3 years57.2447.23121%
Returns for 5 years29.9123.38128%
Returns for 10 yearsN/A78.61-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUE0.58N/A
+0.02%
Cue Biopharma
RNGR13.51N/A
N/A
Ranger Energy Services
MTSR70.50N/A
N/A
Metsera Inc
CHPGU10.26N/A
N/A
Championsgate Acquisition Corp
TRVI11.05-0.26
-2.30%
Trevi Therapeutics